Exelixis, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Alameda, CA
EXEL chart
What traders are saying about $EXEL
Latest postsExelixis, Inc. news
- Form 13D/A EXELIXIS For: 9 November By Investing.com
Investing.com Canada ·
- Eight Farallon funds hold the shares behind a passive stake in Exelixis (EXEL).
Stock Titan ·
- A 12 million-share Exelixis (EXEL) stake falls below the 5% ownership threshold.
Stock Titan ·
- Short Sellers Are Betting Against This Biotech Stock at All-Time Highs, But You Should Still Add it to Your Watchlist
barchart.com ·
- Exelixis, Inc. (EXEL) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
- Exelixis (EXEL) Posts Stronger Earnings, Is The Stock Already 21% Overvalued?
Simply Wall St ·
- Exelixis wins patent appeal, blocks generic launch until 2030
scanx.trade ·
- How Investors May Respond To Exelixis (EXEL) Strong Earnings And Buyback
Simply Wall St ·
- Barclays raises Exelixis price target to $49
scanx.trade ·
- Exelixis stock: Q3 revenue rises as zanzalintinib advances
ad-hoc-news.de ·
- Kuehn Law joins Exelixis probe over fiduciary duty and self-dealing
scanx.trade ·
- Exelixis Is Maintained at Market Perform by Leerink Partners
Moomoo ·
Exelixis, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.32B | $2.17B | $1.83B | $1.61B |
| Net income | $782.6M | $521.3M | $207.8M | $182.3M |
| Diluted EPS | $2.78 | $1.76 | $0.65 | $0.56 |
| Total assets (year end) | $2.84B | $2.95B | $2.94B | $3.07B |
| Cash and equivalents (year end) | $482.5M | $217.4M | $263.0M | $501.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Exelixis, Inc.
- Ticker
- EXEL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Alameda, CA
- Incorporated in
- DE
- Fiscal year end
- January 1
- SEC CIK
- 939767
- Former names
- EXELIXIS INC
Frequently asked questions
What exchange is Exelixis, Inc. listed on?
Exelixis, Inc. trades on the Nasdaq under the ticker symbol EXEL.
What industry is Exelixis, Inc. in?
Exelixis, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Exelixis, Inc. headquartered?
Exelixis, Inc.'s business address on file with the SEC is in Alameda, CA.
When does Exelixis, Inc.'s fiscal year end?
Exelixis, Inc.'s fiscal year ends on January 1.
How much revenue did Exelixis, Inc. report?
Exelixis, Inc. reported $2.32B in revenue for calendar year 2025, according to its SEC filings.